Kazushige Kadota

Interventional cardiologist / Cardiologist

Kurashiki Central Hospital - Okayama, Japan

Latest contributions

EuroPCR 2021 Hotlines / Late-Breaking Trials: POEM, CEL-02, and PENDULUM

21 May 2021 – From EuroPCR 2021

Find out more about various studies & registries in drugs & devices:

POEM study: 1-month DAPT after PCI with bioresorbable-polymer EES in HBR patients
CEL-O2 trial: a novel rapid glycoprotein IIb/IIIa inhibitor(RUC-4) for STEMI patients
PENDULUM registry study: impact of Clinical Outcomes and Platelet Reactivity After Percutaneous Coronary